The Clinical and Economic Benefit of CMV Matching in Kidney Transplant: A Decision Analysis
Conclusions.
Altering national allocation policy to preferentially offer CMV D– organs to CMV R– recipients could improve survival and lower costs after transplant if appropriately implemented.
Source: Transplantation - Category: Transplant Surgery Tags: Original Clinical Science—General Source Type: research
More News: Antiviral Therapy | Cytomegalovirus | Kidney Transplant | Kidney Transplantation | Medicare | Transplant Surgery | Transplants | Urology & Nephrology